View in EDS HTML Full Text PDF Full Text

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Saved in:
Bibliographic Details
Title: Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
Authors: Giles HV; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Hannah.giles@uhb.nhs.uk.; University of Birmingham, Birmingham, UK. Hannah.giles@uhb.nhs.uk., Drayson MT; University of Birmingham, Birmingham, UK., Kishore B; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Pawlyn C; The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK., Kaiser M; The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK., Cook G; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK., de Tute R; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK., Owen RG; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK., Cairns D; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Menzies T; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Davies FE; Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA., Morgan GJ; Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA., Pratt G; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham, Birmingham, UK., Jackson GH; Department of Haematology, University of Newcastle, Newcastle upon Tyne, UK.
Source: Blood cancer journal [Blood Cancer J] 2024 Mar 18; Vol. 14 (1), pp. 50. Date of Electronic Publication: 2024 Mar 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38499538
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Giles+HV%22">Giles HV</searchLink>; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Hannah.giles@uhb.nhs.uk.; University of Birmingham, Birmingham, UK. Hannah.giles@uhb.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Drayson+MT%22">Drayson MT</searchLink>; University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Kishore+B%22">Kishore B</searchLink>; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Kaiser+M%22">Kaiser M</searchLink>; The Institute of Cancer Research, London and The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22de+Tute+R%22">de Tute R</searchLink>; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Owen+RG%22">Owen RG</searchLink>; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Cairns+D%22">Cairns D</searchLink>; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Menzies+T%22">Menzies T</searchLink>; Leeds Cancer Research UK Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Davies+FE%22">Davies FE</searchLink>; Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+GJ%22">Morgan GJ</searchLink>; Myeloma Research Program, Perlmutter Cancer, NYU Langone Health, New York, USA.<br /><searchLink fieldCode="AU" term="%22Pratt+G%22">Pratt G</searchLink>; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Jackson+GH%22">Jackson GH</searchLink>; Department of Haematology, University of Newcastle, Newcastle upon Tyne, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Mar 18; Vol. 14 (1), pp. 50. <i>Date of Electronic Publication: </i>2024 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38499538
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-00995-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 50
    Titles:
      – TitleFull: Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Giles HV
      – PersonEntity:
          Name:
            NameFull: Drayson MT
      – PersonEntity:
          Name:
            NameFull: Kishore B
      – PersonEntity:
          Name:
            NameFull: Pawlyn C
      – PersonEntity:
          Name:
            NameFull: Kaiser M
      – PersonEntity:
          Name:
            NameFull: Cook G
      – PersonEntity:
          Name:
            NameFull: de Tute R
      – PersonEntity:
          Name:
            NameFull: Owen RG
      – PersonEntity:
          Name:
            NameFull: Cairns D
      – PersonEntity:
          Name:
            NameFull: Menzies T
      – PersonEntity:
          Name:
            NameFull: Davies FE
      – PersonEntity:
          Name:
            NameFull: Morgan GJ
      – PersonEntity:
          Name:
            NameFull: Pratt G
      – PersonEntity:
          Name:
            NameFull: Jackson GH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 03
              Text: 2024 Mar 18
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1